Literature DB >> 7972022

Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse.

F Li1, J Guo, Y Fu, G Yan, D Faustman.   

Abstract

Presentation of self-antigens by major histocompatibility complex (MHC) class I molecules requires the function of the MHC class II-linked genes Tap-1 and Tap-2. Evidence suggests that interruption of self-peptide presentation results in reduced cell surface expression of MHC class I molecules and the interruption correlates with progression to diabetic autoimmunity in nonobese diabetic (NOD) mice and humans. NOD mice possess a rare Tap-1 allele (Tap-1b); this is associated with reduced Tap-1 mRNA abundance in lymphocytes from diabetes-prone females and decreased conformationally correct class I molecules on the cell surface. In this study, we demonstrate that, similar to lymphoma cell lines with mutations in Tap-1 or Tap-2, the reduced expression of class I molecules on the surface of lymphocytes from diabetes-prone female NOD mice was normalized by incubation at low temperatures or by exposure to class I allele-specific peptides. As would be expected for cells that express surface class I molecules not associated with peptide, female NOD lymphocytes were resistant to lysis by class I-restricted, peptide-specific cytotoxic T lymphocytes. Furthermore, the rate of class I exit from the endoplasmic reticulum of lymphocytes from female NOD mice was delayed as demonstrated by delayed glycosylation. Male NOD mice, which are not prone to diabetes, lacked these functional defects in class I assembly and had near-normal levels of Tap-1 mRNA and exhibited normal density of class I epitopes that were peptide filled. These results are consistent with the possibility that the rare Tap-1b allele is associated with a quantitative defect in Tap-1 expression that influences disease course.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972022      PMCID: PMC45180          DOI: 10.1073/pnas.91.23.11128

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Major histocompatibility complex (MHC)-encoded HAM2 is necessary for antigenic peptide loading onto class I MHC molecules.

Authors:  Y Yang; K Früh; J Chambers; J B Waters; L Wu; T Spies; P A Peterson
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

2.  Ham-2 corrects the class I antigen-processing defect in RMA-S cells.

Authors:  M Attaya; S Jameson; C K Martinez; E Hermel; C Aldrich; J Forman; K F Lindahl; M J Bevan; J J Monaco
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

3.  Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex.

Authors:  S H Powis; I Mockridge; A Kelly; L A Kerr; R Glynne; U Gileadi; S Beck; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

4.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

5.  Assembly of MHC class I molecules analyzed in vitro.

Authors:  A Townsend; T Elliott; V Cerundolo; L Foster; B Barber; A Tse
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

6.  Class I MHC-restricted recognition of cells expressing a gene encoding a 41 amino acid product of the influenza hemagglutinin.

Authors:  M T Sweetser; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

7.  Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis.

Authors:  H G Ljunggren; S Pääbo; M Cochet; G Kling; P Kourilsky; K Kärre
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

8.  Linkage of faulty major histocompatibility complex class I to autoimmune diabetes.

Authors:  D Faustman; X P Li; H Y Lin; Y E Fu; G Eisenbarth; J Avruch; J Guo
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

9.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex.

Authors:  A Kelly; S H Powis; L A Kerr; I Mockridge; T Elliott; J Bastin; B Uchanska-Ziegler; A Ziegler; J Trowsdale; A Townsend
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

10.  Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene.

Authors:  S Caillat-Zucman; E Bertin; J Timsit; C Boitard; R Assan; J F Bach
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

View more
  11 in total

Review 1.  The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies.

Authors:  Denise L Faustman; Miriam Davis
Journal:  J Mol Med (Berl)       Date:  2009-08-21       Impact factor: 4.599

Review 2.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

3.  A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis.

Authors:  Manjunatha Ankathatti Munegowda; Yulin Deng; Rajni Chibbar; Qingyong Xu; Andrew Freywald; Sean J Mulligan; Sylvia van Drunen Littel-van den Hurk; Deming Sun; Sidong Xiong; Jim Xiang
Journal:  J Clin Immunol       Date:  2011-06-15       Impact factor: 8.317

Review 4.  TNF receptor 2 pathway: drug target for autoimmune diseases.

Authors:  Denise Faustman; Miriam Davis
Journal:  Nat Rev Drug Discov       Date:  2010-05-21       Impact factor: 84.694

5.  NOD mice are defective in proteasome production and activation of NF-kappaB.

Authors:  T Hayashi; D Faustman
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Abnormal T cell selection on nod thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice.

Authors:  V Thomas-Vaslin; D Damotte; M Coltey; N M Le Douarin; A Coutinho; J Salaün
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-05-10

8.  Major histocompatibility complex class I molecule expression is normal on peripheral blood lymphocytes from patients with insulin-dependent diabetes mellitus.

Authors:  W Hao; P Gladstone; S Engardt; C Greenbaum; J P Palmer
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

9.  Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping.

Authors:  H Ikegami; S Makino; E Yamato; Y Kawaguchi; H Ueda; T Sakamoto; K Takekawa; T Ogihara
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

Review 10.  New developments implicating IL-21 in autoimmune disease.

Authors:  Heather M Ren; Aron E Lukacher; Ziaur S M Rahman; Nancy J Olsen
Journal:  J Autoimmun       Date:  2021-07-02       Impact factor: 14.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.